Earnings Call Transcripts
Access detailed transcripts and key takeaways from company earnings calls
All Earnings Calls
Intelligent Protection Management Corporation Q3 2025 Earnings Call - Strategic Integration and Sequential Growth with Focus on Cybersecurity and Managed Services
Intelligent Protection Management Corporation (IPM) reported sequential revenue growth in Q3 2025 following its acquisition and rebranding from New Tech Technology Solutions earlier in the year. The c...
- IPM completed acquisition and rebranding of New Tech Technology Solutions effective January 2, 2025.
- Q3 2025 revenue reached $6.2 million, up 9% sequentially and significantly higher than prior year comparatives.
- Nine-month revenue totaled $17.5 million compared to $0.8 million last year, showing strong top-line growth post-acquisition.
- +10 more takeaways
WEBTOON Entertainment Q3 2025 Earnings Call - Early-Stage Disney Collaboration and IP Adaptation Growth Amid Revenue Challenges
WEBTOON Entertainment reported solid Q3 2025 results with total revenue rising 8.7% year-over-year to $378 million and adjusted EBITDA of $5.1 million, above guidance midpoint. The quarter was highlig...
- WEBTOON delivered 8.7% revenue growth in Q3 2025 to $378 million, surpassing EBITDA guidance with $5.1 million adjusted EBITDA.
- A strategic non-binding agreement with Disney was announced to create a new digital comics platform hosting 35,000+ Disney stories, signaling a transformative partnership but with no near-term material revenue impact.
- Advertising revenue declined 8.9% due to loss of a major Korean e-commerce partner and challenges in Wattpad-impacted markets.
- +7 more takeaways
Aethlon Medical Q2 2026 Earnings Call - Early Clinical Progress and Enrollment Challenges in Oncology Trial
Aethlon Medical reported fiscal Q2 2026 financials, highlighting a cash balance of $5.8 million and a 48% reduction in operating expenses, bringing losses down to $1.5 million. Clinically, the company...
- Aethlon completed chemopurifier treatment in 3 patients in cohort one of Australian oncology trial with no dose-limiting toxicities or serious device-related events.
- Independent safety board approved progress to cohort two, entailing two treatments per week.
- Enrollment challenges persist due to patient hesitancy about extracorporeal therapy and holiday slowdowns.
- +7 more takeaways
GRAIL Q3 2025 Earnings Call - Accelerated FDA PMA Submission and Strong Commercial Momentum Amid Strategic Expansion
GRAIL reported robust Q3 2025 results highlighted by 39% growth in Galleri test volumes and a 29% increase in revenue year-over-year. The company advanced its FDA pre-market approval (PMA) submission ...
- Galleri test volumes surged 39% year-over-year in Q3 2025 with revenue up 29%, fueled by growing provider adoption.
- FDA pre-market approval (PMA) submission timeline refined to Q1 2026, reflecting increased regulatory certainty.
- Pathfinder II registrational study showed a high PPV of 61.6%, specificity of 99.6%, and no serious adverse events, supporting Galleri's safety and efficacy.
- +7 more takeaways
GCT Semiconductor Q3 2025 Earnings Call - First 5G Product Revenue and Production Ramp in Sight
GCT Semiconductor advanced its 2025 'Year of 5G' initiative by recording its first 5G product revenue, signaling a crucial transition to commercial viability. The quarter’s milestones include complete...
- GCT Semiconductor recognized its first 5G product revenue in Q3 2025, marking an early but pivotal commercialization milestone.
- The company successfully completed sampling of its 5G chipsets and modules to lead customers including Airspan Networks and Orbiq.
- Gogo, a leading 5G network operator, plans full commercial service activation using GCT’s 5G chipset before year-end 2025, confirming field testing progress.
- +9 more takeaways
BioRestorative Therapies Q3 2025 Earnings Call - Clinical Progress and Commercial Expansion Drive Optimism
BioRestorative Therapies reported a challenging Q3 2025 with revenues plummeting to $11,800 solely from royalties, down significantly from last year’s $233,600 driven by biocosmeceutical sales. Despit...
- Q3 2025 revenues collapsed to $11,800 from $233,600 in Q3 2024, reflecting timing issues in biocosmeceutical orders and a shift to royalty income.
- Loss from operations widened to $3.7 million compared to $2.3 million a year ago; net loss per share was $3.03 versus $1.13, signaling increased spending or lower revenues.
- Company ended quarter with $4.5 million in cash and equivalents, subsequently adding $1.1 million through financing priced above market, demonstrating investor confidence.
- +13 more takeaways
Dolphin Entertainment Q3 2025 Earnings Call - Strong Organic Growth Drives Profitability and Operational Clarity
Dolphin Entertainment reported a stellar Q3 2025, delivering 16.7% organic revenue growth to $14.8 million and turning operating income positive at $300,000 despite $600,000 in non-cash amortization e...
- Q3 2025 revenue rose 16.7% year-over-year to $14.8 million, marking Dolphin's second highest ever quarterly revenue
- Operating income turned positive at $308,296 despite nearly $600,000 in non-cash amortization expenses
- Adjusted operating income more than doubled year-over-year to approximately $1 million, representing 6.9% of revenue
- +7 more takeaways
Intellinetics 2025 Q3 Earnings Call - SaaS Growth Amidst Professional Services Recovery
Intellinetics reported a mixed third quarter for 2025, with a 12.8% decline in total revenues to $4.0 million due to continued softness in professional services, notably in digital transformation proj...
- Total revenue fell 12.8% to $4.0 million in Q3 2025, primarily due to lower professional services revenue.
- Professional services revenue declined 28% to $1.9 million, attributed to reduced digital transformation work, especially paper scanning.
- Renewal of a large state contract in June has rebuilt backlog, expected to sustain digital transformation work through Q2 2026 without new major deals.
- +12 more takeaways
Aqua Metals Q3 2025 Earnings Call - Strategic growth fueled by $17M capital raise and pilot-scale LFP recycling breakthrough
Aqua Metals reported a quarter marked by significant technical and financial progress. The company raised $17.1 million proactively to extend operational runway, emphasizing measured, disciplined scal...
- Aqua Metals raised $17.1 million proactively, extending operational runway to multiple quarters and affirming financial stability.
- Pilot-scale processing of one metric ton of LFP cathode scrap yielded battery-grade lithium carbonate validated by OEMs and third parties, a unique commercial-scale milestone in the U.S.
- The AquaRefining platform demonstrates feedstock flexibility, targeting both battery and emerging critical mineral supply chains including nickel, cobalt, manganese, and rare earths.
- +9 more takeaways
Aeromexico Q3 2025 Earnings Call - Strong IPO Debut and Resilient Profitability Despite Demand Hurdles
Aeromexico marked its first earnings call as a public company with a solid third quarter performance, delivering the second-best Q3 financial results in its history amid ongoing headwinds. The airline...
- Aeromexico completed a successful IPO and dual listing on NYSE and Mexican Stock Exchange, enhancing capital market profile and governance standards.
- Q3 2025 results were the second-best third quarter in company history with $1.4B revenue, 31% adjusted EBITDAR margin, and 18% operating margin.
- Total revenue per available seat mile (ASM) increased 0.6% excluding 2024’s nonrecurring COVID-related ticket extensions and Boeing compensation items.
- +7 more takeaways